Arteris (NASDAQ:AIP) CEO K Charles Janac Sells 11,145 Shares

by · The Cerbat Gem

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 11,145 shares of the company’s stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $16.90, for a total value of $188,350.50. Following the sale, the chief executive officer owned 139,487 shares in the company, valued at approximately $2,357,330.30. This represents a 7.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

K Charles Janac also recently made the following trade(s):

  • On Friday, January 2nd, K Charles Janac sold 7,823 shares of Arteris stock. The shares were sold at an average price of $15.45, for a total transaction of $120,865.35.
  • On Monday, December 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00.
  • On Friday, December 5th, K Charles Janac sold 60,000 shares of Arteris stock. The stock was sold at an average price of $17.08, for a total transaction of $1,024,800.00.
  • On Thursday, December 4th, K Charles Janac sold 40,000 shares of Arteris stock. The shares were sold at an average price of $16.46, for a total transaction of $658,400.00.
  • On Wednesday, December 3rd, K Charles Janac sold 2,058 shares of Arteris stock. The shares were sold at an average price of $15.52, for a total transaction of $31,940.16.
  • On Tuesday, December 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $14.82, for a total transaction of $18,465.72.

Arteris Stock Down 4.5%

NASDAQ:AIP traded down $0.79 during trading hours on Thursday, hitting $16.63. 374,864 shares of the company’s stock traded hands, compared to its average volume of 450,242. The firm has a market cap of $726.40 million, a P/E ratio of -20.04 and a beta of 1.48. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $19.85. The business’s fifty day simple moving average is $15.27 and its two-hundred day simple moving average is $12.05.

Arteris (NASDAQ:AIPGet Free Report) last announced its earnings results on Tuesday, November 4th. The company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. The business had revenue of $17.41 million during the quarter, compared to the consensus estimate of $17.00 million. On average, analysts expect that Arteris, Inc. will post -0.73 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC bought a new position in Arteris during the 1st quarter worth approximately $1,621,000. Jacobs Levy Equity Management Inc. lifted its position in Arteris by 48.5% in the first quarter. Jacobs Levy Equity Management Inc. now owns 249,517 shares of the company’s stock valued at $1,724,000 after purchasing an additional 81,516 shares during the last quarter. Acadian Asset Management LLC boosted its stake in shares of Arteris by 40.6% during the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after purchasing an additional 260,277 shares during the period. Strs Ohio bought a new position in shares of Arteris in the first quarter worth approximately $104,000. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of Arteris in the second quarter worth $104,000. 64.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on AIP shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, October 8th. Cowen reaffirmed a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Rosenblatt Securities reiterated a “buy” rating and issued a $20.00 target price on shares of Arteris in a research report on Monday, December 15th. TD Cowen raised their price target on Arteris from $15.00 to $16.50 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Finally, Jefferies Financial Group upgraded Arteris to a “hold” rating in a report on Tuesday, October 28th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Arteris currently has a consensus rating of “Moderate Buy” and a consensus target price of $17.50.

Read Our Latest Stock Report on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

See Also